Roopa Industries Ltd is in the business of TPP and its allied productsBusiness Overview: RIL manufactures Bulk Drugs, Drug Intermediates, Nutraceuticals, and fine chemicals. It produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into production of Cephalosporins, Statins etc.,) and Nutraceuticals such...
Roopa Industries has informed shareholders about a special window for share transfers. The company published a notice regarding this in Business Standard and Andhra Prabha. This move aims to facilitate the transfer process for investors, providing a clearer path for shareholders to manage their holdings.
Roopa Industries has confirmed that securities received for dematerialization and re-materialization during the quarter have been listed on stock exchanges. The associated physical certificates were verified, mutilated, and cancelled, with the depository’s name now recorded as the registered owner. This update ensures smooth electronic trading and ownership transfer of the...
Roopa Industries Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income from operations at Rs. 34.97 Cr for the quarter and Rs. 113.02 Cr for the year. Net profit before tax stood at Rs. 14.68 Cr for the...
Roopa Industries Limited has submitted its Annual Secretarial Compliance Report for the financial year ending March 31, 2025, certified by a practicing company secretary. The report confirms full compliance with applicable SEBI regulations, circulars, and guidelines, with no observations or penalties during the review period. Key governance areas including board...
Roopa Industries Limited has confirmed the completion of the dematerialization and rematerialization process for its securities, as verified by Aarthi Consultants, the company's registrar and transfer agent. The securities have been properly listed on stock exchanges, with the associated certificates mutilated and canceled. This operational update ensures streamlined securities management...
